Medicaid

BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart Failure

SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. , a global leader in cellular and cell-derived therapeutics for the...

Acentra Health Awarded $27.5 Million Contract from California Medicaid to Continue Providing Preadmission Screening and Resident Review (PASRR) Services

Award follows new contracts in Kansas and Washington and expands the company’s PASRR services for long-term care assessments to eight...

Acentra Health Awarded $27.5 Million Contract from California Medicaid to Continue Providing Preadmission Screening and Resident Review (PASRR) Services

Award follows new contracts in Kansas and Washington and expands the company’s PASRR services for long-term care assessments to eight...

Hixny’s Snapshot Application Now Available to All Providers in New York

In a new SHIN-NY collaboration, Hixny has made it easy for providers across the stateto screen patients for HRSN and query the state's controlled substance database. ALBANY, N.Y., April 28, 2025 /PRNewswire/ -- Hixny, New York's cutting-edge health information...

Coy Gupta Joins Glytec as Chief Technology Officer to Innovate and Enhance AI Capabilities of Industry Leading Medical Software Platform

BOSTON, April 24, 2025 /PRNewswire/ -- Glytec, the Software-as-a-Service (SaaS) technology leader and pioneer in diabetes and insulin management, is proud...

error: Content is protected !!